Now Ashwagandha for prophylaxis treatment of COVID-19
Union Health Minister Harsh Vardhan and AYUSH Minister Shripad Yesso Naik on Thursday jointly launched three Central AYUSH ministry-based studies related to COVID-19
Union Health Minister Harsh Vardhan and AYUSH Minister Shripad Yesso Naik on Thursday jointly launched three Central AYUSH ministry-based studies related to COVID-19. The AYUSH-based studies include Study on Ayurveda interventions as prophylaxis and as an add on to standard care to COVID-19, Population-based interventional studies on the impact of AYUSH-based prophylactic interventions, and AYUSH Sanjivani App-based study for impact assessment of acceptance and usage of AYUSH advisories in prevention of COVID-19.
The Interdisciplinary Ayush R&D Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organisations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi and Pippali and a poly herbal formulation (AYUSH-64).
The study will draw a comparison between the impact of Hydroxychloroquine and Ashwagandha for the prophylaxes against SARS-COV-2 in the health care providers with increased risk during the COVID-19 Pandemic.
It will also include effectiveness of Ayurveda Formulation as an adjunct to `Standard of Care` for the treatment of Mild to Moderate COVID-19. A Randomized, Open Label, Parallel Efficacy, Active Control, Multi-Centre Exploratory Drug Trial will take place.
The population based interventional studies on impact of AYUSH based prophylactic interventions will Abe carried out through four Research Councils under Ministry of AYUSH and National Institutes in 25 states across the country and several State Governments covering approximately 5 lakhs population.
The core objectives consist of, assessment of preventive potential of AYUSH interventions for COVID-19 and also to assess the improvement in Quality of Life in high risk population.
The Health Minister at the video conference hailed the efforts of Naik for containing the disease well in Goa.
"You made Goa corona free," said the minister. He also added "we should not hesitate using our traditional medicines. Studies show that even China has used its traditional medicines and treatment methods on COVID-19 patients there".
See Zee Business Live TV Streaming Below:
Harsh Vardhan assured the officials that the outcome of the study would certainly pave a new horizon in understanding the preventive potential of AYUSH interventions during pandemics like COVID-19 through scientific evidence.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
Top Gold ETF vs Top Large Cap Mutual Fund 10-year Return Calculator: Which has given higher return on Rs 11 lakh investment; see calculations
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
12:55 PM IST